Czech Republic adds Adamed’s Zahron Combi to reimbursement list

…list from 1 July, Medical Tribune reported. Marketed by pharmaceutical company Adamed, the drug is a fixed combination of rosuvastatin and amlodipine. General practitioners and cardiologists will be able to prescribe it in the treatment of hypertension and hyperlipoproteinemia.

Sign up now to open the entire news item.

You are allowed to open only one news item from PMR websites.
  • 1E-mail
    (to send requested information)
  • 2Brief profile
    (required for new e-mails only)

 required fields

You must accept PMR’s Privacy Policy.